Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Sublingual Nitroglycerin on Absolute Coronary Blood Flow
NCT06823843Phase 4Completed
- Sponsor
- Cardiovascular Research Center Aalst
- Start
- Jul 2024
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in angina pectoris comparing Nitroglycerin Group with Placebo Group (2 arms). Primary endpoint: Change from baseline in the absolute coronary flow at 10 minutes. Started Jul 2024; status: completed.
02
Drugs
nitroglycerin
03
Conditions
angina pectoris
Beyond the preview
Go deeper on NCT06823843.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06823843.